JP2020505038A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020505038A5 JP2020505038A5 JP2019539835A JP2019539835A JP2020505038A5 JP 2020505038 A5 JP2020505038 A5 JP 2020505038A5 JP 2019539835 A JP2019539835 A JP 2019539835A JP 2019539835 A JP2019539835 A JP 2019539835A JP 2020505038 A5 JP2020505038 A5 JP 2020505038A5
- Authority
- JP
- Japan
- Prior art keywords
- culture medium
- pluripotent stem
- stem cells
- acid
- mammalian pluripotent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000010367 cloning Methods 0.000 claims 18
- 210000001778 pluripotent stem cell Anatomy 0.000 claims 16
- 239000013589 supplement Substances 0.000 claims 16
- 239000001963 growth medium Substances 0.000 claims 15
- 238000000034 method Methods 0.000 claims 8
- 150000002632 lipids Chemical class 0.000 claims 7
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims 6
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims 6
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims 6
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims 6
- 210000004027 cell Anatomy 0.000 claims 6
- 210000002744 extracellular matrix Anatomy 0.000 claims 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims 6
- 230000004083 survival effect Effects 0.000 claims 6
- 238000012258 culturing Methods 0.000 claims 5
- 239000003112 inhibitor Substances 0.000 claims 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims 3
- 102000009027 Albumins Human genes 0.000 claims 3
- 108010088751 Albumins Proteins 0.000 claims 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims 3
- 239000005642 Oleic acid Substances 0.000 claims 3
- 235000021314 Palmitic acid Nutrition 0.000 claims 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims 3
- 229940114079 arachidonic acid Drugs 0.000 claims 3
- 235000021342 arachidonic acid Nutrition 0.000 claims 3
- 230000002708 enhancing effect Effects 0.000 claims 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims 3
- 229960004488 linolenic acid Drugs 0.000 claims 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims 3
- 238000010899 nucleation Methods 0.000 claims 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 3
- 230000035755 proliferation Effects 0.000 claims 3
- 150000003384 small molecules Chemical class 0.000 claims 3
- 239000006143 cell culture medium Substances 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 238000001879 gelation Methods 0.000 claims 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 claims 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 claims 2
- 230000037361 pathway Effects 0.000 claims 2
- 239000011435 rock Substances 0.000 claims 2
- 239000002356 single layer Substances 0.000 claims 2
- UNSRRHDPHVZAHH-YOILPLPUSA-N (5Z,8Z,11Z)-icosatrienoic acid Chemical compound CCCCCCCC\C=C/C\C=C/C\C=C/CCCC(O)=O UNSRRHDPHVZAHH-YOILPLPUSA-N 0.000 claims 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims 1
- XDHJBIYJRNFDKS-IBGZPJMESA-N 1-[(4-methoxyphenyl)methyl]-5-[(2s)-2-(pyridin-3-yloxymethyl)pyrrolidin-1-yl]sulfonylindole-2,3-dione Chemical compound C1=CC(OC)=CC=C1CN1C2=CC=C(S(=O)(=O)N3[C@@H](CCC3)COC=3C=NC=CC=3)C=C2C(=O)C1=O XDHJBIYJRNFDKS-IBGZPJMESA-N 0.000 claims 1
- KHZOJCQBHJUJFY-UHFFFAOYSA-N 2-[4-(2-methylpyridin-4-yl)phenyl]-n-(4-pyridin-3-ylphenyl)acetamide Chemical compound C1=NC(C)=CC(C=2C=CC(CC(=O)NC=3C=CC(=CC=3)C=3C=NC=CC=3)=CC=2)=C1 KHZOJCQBHJUJFY-UHFFFAOYSA-N 0.000 claims 1
- GNCZTZCPXFDPLI-UHFFFAOYSA-N 4-chloro-2-[[oxo-[3-(trifluoromethyl)anilino]methyl]amino]benzoic acid Chemical compound OC(=O)C1=CC=C(Cl)C=C1NC(=O)NC1=CC=CC(C(F)(F)F)=C1 GNCZTZCPXFDPLI-UHFFFAOYSA-N 0.000 claims 1
- UNSRRHDPHVZAHH-UHFFFAOYSA-N 6beta,11alpha-Dihydroxy-3alpha,5alpha-cyclopregnan-20-on Natural products CCCCCCCCC=CCC=CCC=CCCCC(O)=O UNSRRHDPHVZAHH-UHFFFAOYSA-N 0.000 claims 1
- AQGNHMOJWBZFQQ-UHFFFAOYSA-N CT 99021 Chemical compound CC1=CNC(C=2C(=NC(NCCNC=3N=CC(=CC=3)C#N)=NC=2)C=2C(=CC(Cl)=CC=2)Cl)=N1 AQGNHMOJWBZFQQ-UHFFFAOYSA-N 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 claims 1
- 229920000858 Cyclodextrin Polymers 0.000 claims 1
- 102000016942 Elastin Human genes 0.000 claims 1
- 108010014258 Elastin Proteins 0.000 claims 1
- 108010067306 Fibronectins Proteins 0.000 claims 1
- 102000016359 Fibronectins Human genes 0.000 claims 1
- 229920002971 Heparan sulfate Polymers 0.000 claims 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 1
- 108010085895 Laminin Proteins 0.000 claims 1
- 102000007547 Laminin Human genes 0.000 claims 1
- 102100037369 Nidogen-1 Human genes 0.000 claims 1
- 235000021319 Palmitoleic acid Nutrition 0.000 claims 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims 1
- 108010067787 Proteoglycans Proteins 0.000 claims 1
- 235000021355 Stearic acid Nutrition 0.000 claims 1
- 108010031318 Vitronectin Proteins 0.000 claims 1
- 102100035140 Vitronectin Human genes 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000000853 adhesive Substances 0.000 claims 1
- 230000001070 adhesive effect Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- 229920002549 elastin Polymers 0.000 claims 1
- 210000001671 embryonic stem cell Anatomy 0.000 claims 1
- 210000001808 exosome Anatomy 0.000 claims 1
- 210000004263 induced pluripotent stem cell Anatomy 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 1
- 239000011976 maleic acid Substances 0.000 claims 1
- 108010082117 matrigel Proteins 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 229940050561 matrix product Drugs 0.000 claims 1
- 239000002609 medium Substances 0.000 claims 1
- 108010008217 nidogen Proteins 0.000 claims 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims 1
- 229920001993 poloxamer 188 Polymers 0.000 claims 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 1
- 239000008117 stearic acid Substances 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762449413P | 2017-01-23 | 2017-01-23 | |
| US62/449,413 | 2017-01-23 | ||
| US201762518776P | 2017-06-13 | 2017-06-13 | |
| US62/518,776 | 2017-06-13 | ||
| US201762608875P | 2017-12-21 | 2017-12-21 | |
| US62/608,875 | 2017-12-21 | ||
| PCT/CA2018/050076 WO2018132926A1 (en) | 2017-01-23 | 2018-01-23 | Media and methods for enhancing the survival and proliferation of stem cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020505038A JP2020505038A (ja) | 2020-02-20 |
| JP2020505038A5 true JP2020505038A5 (enExample) | 2021-07-26 |
| JP7049347B2 JP7049347B2 (ja) | 2022-04-06 |
Family
ID=62907538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019539835A Active JP7049347B2 (ja) | 2017-01-23 | 2018-01-23 | 幹細胞の生存および増殖を高めるための培地および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11697796B2 (enExample) |
| EP (2) | EP4361256A3 (enExample) |
| JP (1) | JP7049347B2 (enExample) |
| CN (1) | CN110462025B (enExample) |
| AU (1) | AU2018209127B2 (enExample) |
| CA (1) | CA3051141C (enExample) |
| IL (1) | IL268194B (enExample) |
| SG (1) | SG11201906731XA (enExample) |
| WO (1) | WO2018132926A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3051141C (en) | 2017-01-23 | 2021-06-22 | Stemcell Technologies Canada Inc. | Media and methods for enhancing the survival and proliferation of stem cells |
| CN111808797A (zh) * | 2020-07-28 | 2020-10-23 | 湖南赛诺生物科技股份有限公司 | Necrostatin-1的应用及促进新生猪胰岛细胞成熟的制剂 |
| JP2022032793A (ja) * | 2020-08-14 | 2022-02-25 | アルブキュラ コーポレーション | アルブミン組成物並びにそれを製造及び使用する方法 |
| IL300809A (en) | 2020-09-02 | 2023-04-01 | Yztherapeutic Performance Ltd | Cellular preparation for the treatment of diseases and method of use |
| WO2022114724A1 (ko) * | 2020-11-27 | 2022-06-02 | (주)엑셀세라퓨틱스 | 고효율 및 고순도 엑소좀 생산용 배지 조성물 |
| WO2022173058A1 (ja) * | 2021-02-15 | 2022-08-18 | 凸版印刷株式会社 | 三次元組織体の製造方法及び脂肪由来幹細胞の分化促進方法 |
| CN116121186A (zh) * | 2023-01-03 | 2023-05-16 | 内蒙古奥普赛生物科技有限公司 | 一种利用棕榈油酸培养脂肪间充质干细胞的方法 |
| WO2024216399A1 (en) * | 2023-04-20 | 2024-10-24 | Stemcell Technologies Canada Inc. | Methods for large scale expansion of pluripotent stem cells (pscs) |
| CN116814532B (zh) * | 2023-07-10 | 2025-02-11 | 上海迈邦生物科技有限公司 | 一种用于哺乳动物细胞培养基的脂类复合物及其制备方法与应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0986635A4 (en) | 1997-01-10 | 2001-11-07 | Life Technologies Inc | SERUM SUBSTITUTE FOR EMBRYONIC STEM CELLS |
| ES2383813T3 (es) | 2004-09-08 | 2012-06-26 | Wisconsin Alumni Research Foundation | Método de cultivo y cultivo de células madre embrionarias |
| US9074176B2 (en) * | 2006-01-13 | 2015-07-07 | Two Cells Co., Ltd. | Culture medium additive for use in serum-free culturing of animal cell, kit and use thereof |
| US8241908B2 (en) | 2006-05-16 | 2012-08-14 | Becton, Dickinson And Company | Extracellular matrix coated surface for culturing cells |
| GB0613756D0 (en) | 2006-07-12 | 2006-08-23 | Univ Sheffield | Cell culture medium |
| ES2360782B1 (es) | 2009-07-28 | 2012-03-12 | Grifols, S.A. | Medios para cultivo de células de mamíferos que comprenden sobrenadante de etapas del fraccionamiento de Cohn y uso de los mismos. |
| FI20096288A0 (fi) * | 2009-12-04 | 2009-12-04 | Kristiina Rajala | Formulations and methods for culturing stem cells |
| WO2011085072A2 (en) | 2010-01-06 | 2011-07-14 | Ervin Industries, Inc. | Frangible, ceramic-metal composite objects and methods of making the same |
| JP6148429B2 (ja) | 2011-01-31 | 2017-06-14 | 協和発酵バイオ株式会社 | ヒト多能性幹細胞の培養方法 |
| US8497124B2 (en) * | 2011-12-05 | 2013-07-30 | Factor Bioscience Inc. | Methods and products for reprogramming cells to a less differentiated state |
| RU2018128383A (ru) | 2012-03-07 | 2019-03-14 | Янссен Байотек, Инк. | Среда определенного состава для размножения и обновления плюрипотентных стволовых клеток |
| JP2016521971A (ja) * | 2013-04-23 | 2016-07-28 | イェダ リサーチ アンド ディベロップメント カンパニー リミテッド | 単離ナイーブ型多能性幹細胞およびそれを発生させる方法関連出願本出願は、米国特許法１１９条第（ｅ）項に基づき、２０１４年１月２９日出願の米国特許仮出願第６１／９３２，９３５号、２０１３年９月１７日出願の米国特許仮出願第６１／８７８，７６９号、および２０１３年４月２３日出願の米国特許仮出願第６１／８１４，９２０号の優先権を主張する。また、本出願は、同時に提出された同出願人による同時係属出願である、ＹａｑｕｂＨＡＮＮＡ、ＮｏａＮＯＶＥＲＳＨＴＥＲＮ、およびＹｏａｃｈＲＡＩＳによる米国特許出願（発明の名称「単離ナイーブ型多能性幹細胞およびそれを発生させる方法（ＩＳＯＬＡＴＥＤＮＡＩＶＥＰＬＵＲＩＰＯＴＥＮＴＳＴＥＭＣＥＬＬＳＡＮＤＭＥＴＨＯＤＳＯＦＧＥＮＥＲＡＴＩＮＧＳＡＭＥ）」）（代理人事件記録簿第５８８７０号）にも関する。上記出願の内容はその全体を参考として本明細書に組み込む。 |
| SG11201509767UA (en) | 2013-05-30 | 2015-12-30 | Ajinomoto Kk | Medium for culturing stem cells |
| WO2015042356A1 (en) * | 2013-09-19 | 2015-03-26 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Chemically defined culture medium for stem cell maintenance and differentiation |
| CA2981277A1 (en) * | 2015-03-30 | 2016-10-06 | Ajinomoto Co., Inc. | Human serum albumin-containing culture medium for growth of neural stem cells |
| CA3051141C (en) | 2017-01-23 | 2021-06-22 | Stemcell Technologies Canada Inc. | Media and methods for enhancing the survival and proliferation of stem cells |
-
2018
- 2018-01-23 CA CA3051141A patent/CA3051141C/en active Active
- 2018-01-23 EP EP24162728.0A patent/EP4361256A3/en active Pending
- 2018-01-23 EP EP18741389.3A patent/EP3571290B1/en active Active
- 2018-01-23 SG SG11201906731XA patent/SG11201906731XA/en unknown
- 2018-01-23 WO PCT/CA2018/050076 patent/WO2018132926A1/en not_active Ceased
- 2018-01-23 AU AU2018209127A patent/AU2018209127B2/en active Active
- 2018-01-23 CN CN201880019192.7A patent/CN110462025B/zh active Active
- 2018-01-23 US US16/480,025 patent/US11697796B2/en active Active
- 2018-01-23 JP JP2019539835A patent/JP7049347B2/ja active Active
-
2019
- 2019-07-21 IL IL268194A patent/IL268194B/en unknown
-
2023
- 2023-03-15 US US18/184,517 patent/US20230250392A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020505038A5 (enExample) | ||
| JP7391072B2 (ja) | 造血幹細胞の増大、富化、および維持に関する方法および組成物 | |
| US20210171885A1 (en) | Method for producing cell aggregates | |
| Shi et al. | Smooth muscle cell differentiation: model systems, regulatory mechanisms, and vascular diseases | |
| CA2675445C (en) | Improved culture of stem cells | |
| CN108884441B (zh) | 集落形成培养基及其用途 | |
| CA2760768C (en) | Lung tissue model | |
| JP6949336B2 (ja) | 人工多能性幹細胞由来腸管幹細胞の維持培養 | |
| Wolfe et al. | Effects of shear stress on germ lineage specification of embryonic stem cells | |
| AR098875A1 (es) | Medios para cultivo celular | |
| AU2018209127B2 (en) | Media and methods for enhancing the survival and proliferation of stem cells | |
| MX350951B (es) | Composiciones y metodos para tratar enfermedades retinales. | |
| EP3219790A1 (en) | Myocardial cell sheet | |
| JP2015516161A5 (enExample) | ||
| JP2016534731A5 (enExample) | ||
| EA201400401A1 (ru) | Биокомпозит для регенерации поврежденных тканей и органов, набор для изготовления биокомпозита и способ лечения | |
| JP2018531021A5 (enExample) | ||
| JP2012143229A5 (enExample) | ||
| Hoxha et al. | Histone deacetylase 1 deficiency impairs differentiation and electrophysiological properties of cardiomyocytes derived from induced pluripotent cells | |
| JP6744084B2 (ja) | 幹細胞由来の分化細胞用培地、幹細胞からの分化細胞の製造及び該分化細胞を含む細胞医薬組成物の製造のための方法 | |
| Hoshiba et al. | Effects of extracellular matrices derived from different cell sources on chondrocyte functions | |
| JP6247932B2 (ja) | 細胞培養装置 | |
| Ohnuki et al. | Effects of hanging drop culture conditions on embryoid body formation and neuronal cell differentiation using mouse embryonic stem cells: optimization of culture conditions for the formation of well-controlled embryoid bodies | |
| Vukusic et al. | High density sphere culture of adult cardiac cells increases the levels of cardiac and progenitor markers and shows signs of vasculogenesis | |
| Ma et al. | Human amniotic fluid stem cells support undifferentiated propagation and pluripotency of human embryonic stem cell without b-FGF in a density dependent manner |